Literature DB >> 20451418

Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy.

Martine Ploeg1, Lambertus A L M Kiemeney, Geert A Smits, Henk Vergunst, Andre C Viddeleer, Arno D H Geboers, Hans van Berkel, Erika van Boven, Katja K H Aben, J Alfred Witjes.   

Abstract

OBJECTIVES: In muscle invasive bladder cancer (MIBC), careful clinical staging is essential for patient counseling and decision-making. Bimanual palpation (BP) is an integral part and guideline advice of clinical staging. Until now, however, the value of BP has never been studied. With this study, we aim to determine the accuracy of clinical staging through BP.
METHODS: Detailed clinical data were collected from a population-based series of 1,409 patients with MIBC, diagnosed between 1989 and 2005, in the region of the Comprehensive Cancer Centre East in The Netherlands. Selected were all patients who underwent BP (n = 738). Preoperative tumor-stage (cT-stage) determined through BP was compared with post-cystectomy pT-stage. Contingency tables were made to determine the correlation between cT-stage and pT-stage.
RESULTS: In 18 of 142 patients in whom BP showed an organ-confined tumor, the tumor was unresectable (pT4) at the time of surgery. Four out of 9 patients who had a suspected T4 tumor on BP but who underwent cystectomy anyway appeared to have operable tumors at cystectomy. In 87 patients (57.6%), accurate staging through BP was observed. In 17 patients (11.3%), clinical overstaging was found, and in 47 patients, (31.1%) clinical understaging.
CONCLUSIONS: Frequently, pT-stage after cystectomy does not correlate with preoperative cT-stage based on BP. Discrepancy was observed in 42% of the patients: in 11%, clinical overstaging and in 31%, clinical understaging. Based on these data, some caution is suggested when interpreting the outcome of BP. Prospective data is needed for a more formal evaluation of the staging accuracy of BP.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20451418     DOI: 10.1016/j.urolonc.2009.12.020

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  11 in total

1.  The utility of an extensive postchemotherapy staging evaluation in patients receiving neoadjuvant chemotherapy for bladder cancer.

Authors:  Adam C Reese; Mark W Ball; Nilay Gandhi; Michael A Gorin; George J Netto; Trinity J Bivalacqua; Mark P Schoenberg
Journal:  Urology       Date:  2014-08       Impact factor: 2.649

2.  Bimanual palpation for staging of bladder cancer-clinical use and its predictors.

Authors:  Lukasz Bialek; Slawomir Poletajew; Piotr Maciej Magusiak; Mikolaj Ostrach; Jakub Szpernalowski; Bartosz Dybowski; Piotr Radziszewski
Journal:  Turk J Urol       Date:  2018-11-21

3.  Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy?

Authors:  Jay G Fuletra; Andrew Watts; Matthew G Kaag; Erik Lehman; Jay D Raman; Suzanne B Merrill
Journal:  World J Urol       Date:  2020-07-28       Impact factor: 4.226

Review 4.  Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.

Authors:  Andrew H Feifer; Jennifer M Taylor; Tatum V Tarin; Harry W Herr
Journal:  Eur Urol       Date:  2011-01-18       Impact factor: 20.096

5.  Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort.

Authors:  Nicholas E Power; Wassim Kassouf; David Bell; Armen G Aprikian; Yves Fradet; Louis Lacombe; Joseph Chin; Jonathan Izawa; Eric Estey; Adrian Fairey; Ilias Cagiannos; Jean-Baptiste Lattouf; Darrel Drachenberg; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

6.  The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.

Authors:  William P Parker; Philip L Ho; Stephen A Boorjian; Jonathan J Melquist; Prabin Thapa; Jeffrey M Holzbeierlein; Igor Frank; Ashish M Kamat; Eugene K Lee
Journal:  World J Urol       Date:  2016-03-04       Impact factor: 4.226

7.  Scoring system for prediction of lymph node metastasis in radical cystectomy cohort.

Authors:  Miroslav M Stojadinović; Rade Prelević; Arso Vukićević
Journal:  Int Urol Nephrol       Date:  2014-01-29       Impact factor: 2.370

8.  T-helper 1 immunoreaction influences survival in muscle-invasive bladder cancer: proof of concept.

Authors:  Alexandre Ingels; Rafael E Sanchez Salas; Vincent Ravery; Gaëlle Fromont-Hankard; Pierre Validire; Jean-Jacques Patard; Géraldine Pignot; Dominique Prapotnich; Fabien Olivier; Marc Galiano; Eric Barret; Francois Rozet; Nina Weber; Xavier Cathelineau
Journal:  Ecancermedicalscience       Date:  2014-12-01

9.  Assessment of the infiltrative character of bladder cancer at the time of transurethral resection: a single center study.

Authors:  Paweł Grzegółkowski; Krystian Kaczmarek; Artur Lemiński; Michał Soczawa; Adam Gołąb; Marcin Słojewski
Journal:  Cent European J Urol       Date:  2016-12-30

Review 10.  Bladder preservation with brachytherapy compared to cystectomy for T1-T3 muscle-invasive bladder cancer: a systematic review.

Authors:  Manouk K Bos; Rafael Ordoñez Marmolejo; Coen R N Rasch; Bradley R Pieters
Journal:  J Contemp Brachytherapy       Date:  2014-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.